Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma - Rodriguez, Tulio E.; Hari, Parameswaran; Stiff, Patrick J.; Smith, Scott E.; Sterrenberg, Danielle; Vesole, David H. (Biology of blood and marrow transplantation, 2016)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - toxicity; Bortezomib; Bortezomib - administration & dosage; Busulfan; Busulfan - administration & dosage; Case-Control Studies; Conditioning regimen; Female; Hematology, Oncology and Palliative Medicine; Hematopoietic Stem Cell Transplantation - methods; Hematopoietic Stem Cell Transplantation - mortality; Hematopoietic Stem Cell Transplantation - standards; Humans; Male; Melphalan; Melphalan - administration & dosage; Middle Aged; Multiple myeloma; Multiple Myeloma - mortality; Multiple Myeloma - therapy; Myeloablative Agonists - therapeutic use; Myeloablative Agonists - toxicity; Stem cell transplantation; Transplantation Conditioning - methods; Transplantation Conditioning - mortality; Transplantation Conditioning - standards; Transplantation, Autologous; Treatment Outcome; Conditioning regimen; Stem cell transplantation; Bortezomib; Busulfan; Multiple myeloma; Melphalan